Objective: Melanocortin-4 receptor (MC4R) deficiency is the most common cause of monogenic obesity. In the present study, we screened the MC4R gene for mutations in a population of overweight and obese children and adolescents. Method: Cross-sectional mutation analysis of 112 overweight/obese children and adolescents and 121 lean individuals. Results: We identified 11 sequence variations, 5 of which were present in our control population or had been previously reported as polymorphisms. The remaining 6 variations are disease-causing mutations including 2 novel ones: a I186V mutation and a F280L mutation. The 4 previously described mutations (D90N, M200V, P260Q, Q307X) were identified in single probands. Using confocal imaging, we demonstrated that F280L and P260Q cause intracellular retention of the mutant receptor. No difference in cell surface expression could be detected for the I186V mutation. Using a cAMP responsive luciferase vector, we demonstrated that the receptor with I186V is unable to activate its intracellular signaling pathway while the P260Q mutation causes reduced activation of the receptor. Conclusion: We detected MC4R deficiency in 6 patients from our cohort, amounting to a prevalence of 5.3%. Two novel mutations were identified. We also confirmed that intracellular retention is a common pathogenic effect of MC4R mutations.
Obesityisoneofthemostimportanthealthproblemsintoday'sworld.Itiscausedmainlybyaninteractionbetweenenvironmental and genetic factors. However, several studies haveshownthatobesitycanalsobecausedbyamutationina single gene. These monogenic forms of obesity have been foundtobecausedbymutationsinthegenesencodingleptin [1] ,leptinreceptor [2] ,prohormoneconvertase1 [3] ,proopiomelanocortin [4] ,melanocortin-3receptor [5, 6] ,melanocortin-4receptor(MC4R) [7, 8] andsingleminded1 [9] .MC4R deficiencyhasproventobethemostcommoncauseofmonogenic obesity, with a frequency of about 2.5% in the obese population [10] .
The MC4R is a 7 transmembrane receptor expressed in the hypothalamus [11, 12] . This receptor is activated by α-melanocytestimulatinghormone(α-MSH),itsendogenous agonist,andisantagonizedbyagouti-relatedpeptide(AgRP) [11] [12] [13] .Leptinstimulatestheproductionofproopiomelanocortin,theprecursorofα-MSHandinhibitstheexpressionof AgRP, thus generating an anorexigenic signal. The crucial roleoftheMC4Rinfoodintakeregulationwasdemonstrated throughgenerationofaknock-outmouse.Huszaretal. [14] showedthatMC4Rknock-outmicedisplayamaturity-onset obesityphenotypewithhyperphagia,increasedlineargrowth, hyperinsulinemia and hyperglycemia. In 1998, two groups simultaneouslyreportedthefirsthumanmutationsinMC4R: they found a deletion and insertion which completely abolished receptor function. Probands carrying these mutations hadsevereearly-onsetobesityandhyperphagiawithoutother complications [7, 8] .Sincethen,MC4Rhasbeenwidelystud-ObesFacts2010;3:304-311
NewMutationsintheMelanocortin-4 Receptor 305 iedinseveralpopulationsofobeseadultsandchildren.Mutationfrequenciesvaryconsiderablybetweenpopulations,rangingfrom0.5to6% [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] .
Most mutations were found in the heterozygous state, althoughsomehomozygousmutationshavealsobeenreported [19, [25] [26] [27] [28] .SeveralMC4Rmutationshavebeenfunctionally characterized. They were mostly found to impair proper receptor trafficking to the plasma membrane, and the mutant receptorswerethereforefoundtoberetainedintracellularly [29] [30] [31] .Mutationscanalsoimpairreceptorfunctionthrough affectingligandbinding,constitutiveactivityandagonist-stimulatedsignaling [32, 33] .
Recently,MC4Rhasalsobeenimplicatedintheetiologyof complexobesity.Agenome-wideassociationstudyidentified variants downstream from MC4R to be significantly associatedwithcommonobesityinCaucasianpopulations [34] .This finding was subsequently replicated by several other investigators [35] [36] [37] [38] andisnowacceptedasagenuineassociationsignalforcomplexobesity.Thesefindingsdemonstrate that MC4R is important in the development of both monogenicobesityandcommonobesity.
Previously,wereportedthatnomutationswerepresentin a population of Belgian obese adults, adolescents and children [39] .Inthecurrentstudy,wepresentdatafromamutation analysis in a second group of overweight and obese childrenandadolescents.
Material and Methods
Subjects 112 unrelated overweight and obese children and adolescents (51 boys and61girls;adolescencedefinedasage≥12years;table1)consultingthe Child Obesity Clinics from the Antwerp University Hospital and the VirgaJesseHospital,Hasselt,bothinBelgium,wererecruited.Thepatient population has a mixed ethnicity. The percentile lines that pass throughtheBMIof25and30at18yearsofageontheFlemishage-and sex-specific BMI growth curves are used as cut-off for the diagnosis of overweight and obesity in our cohort [40] . For patients carrying MC4R mutations, parents and other family members, if available, were contactedforinclusioninthestudy.Acontrolpopulationof121leansubjects wasalsoexaminedformutationsinMC4R(inclusioncriterium:BMIbetween18.5and25kg/m 2 ).AllcontrolsubjectswererecruitedamongpersonnelfromAntwerpUniversityHospitalandtheDepartmentofMedicalGenetics.AllcontrolsubjectwereofCaucasianorigin(table1).All participantsgavetheirwritteninformedconsent.Thestudyprotocolwas approvedbythelocalethicscommittee.
Anthropometry
Heightwasmeasuredtothenearest0.1cm.Weightwasmeasuredona digitalscaletothenearest0.1kg.BMIwascalculatedforallpatients,and Z-scoreswerebasedontheFlemishgrowthcurves [40] .
Mutation Analysis of MC4R TheMC4RgenewasamplifiedbyPCRongenomicDNAisolatedfrom wholeblood.TheentirecodingregionofMC4R(999bp)wasscreened formutationsusingdenaturinghighperformanceliquidchromatography (DHPLC)orhigh-resolutionmeltingcurveanalysis(HRM).Thecontrol populationwasscreenedwithbothmethods.DHPLCanalysiswascarried outasdescribedpreviously [39] .Briefly,MC4Rwasdividedinto3ampli-conswhichwereallanalyzedonaWAVENucleicAcidFragmentAnalysisSystem(TransgenomicInc,Crewe,UK).Sampleswithaberrantchromatogramscomparedtowildtypeweresequencedtoconfirmandidentify nucleotide changes. For HRM, the coding region of MC4R was dividedinto4amplicons.HRMwasperformedusingtheLightcyclerLC480 Real-TimePCRSystem(Roche,Penzberg,Germany)withincorporation of LCGreen+ fluorescent dye (Idaho Technology Inc., Salt Lake City, UT,USA)intothePCRproduct.Sampleswithmeltingcurvesdeviating from wild type were sequenced. Sequencing was performed with ABI BigDyeTerminatorv1.1CycleSequencingkitsonanABIPrismGenetic Analyzer3130xl(AppliedBiosystemsInc,FosterCity,CA,USA).Primer sequences for DHPLC, HRM and sequencing are available upon request.
Subcellular Localization of Mutant Receptor
Wild-typeMC4RwasamplifieddirectlyfromgenomicDNAofacontrol individual using primers which add a NheI (5'-ATC GAT GCT AGC TCC TGC CAG CAT GGT GAA CTC C-3') and a HindIII (5'-GTA ACT AAG CTT ATA TCT GCT AGA CAA GTC-3') restriction site upstream and downstream of MC4R respectively. PCR was performed using iProof High-Fidelity DNA polymerase (Bio-Rad, Hercules, CA, USA), according to the manufacturer's protocol. Using NheI and HindIII,wild-typeMC4Rwasclonedintothemammalianexpressionvector pEGFP-N1(Clontech,MountainView,CA,USA)whichaddsaC-terminal EGFP tag to MC4R. Mutant receptors carrying I186V, P260Q or F280L were created with in vitro mutagenesis using a Quikchange Site Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA). All cloned products were sequenced using a standard sequencing protocol as describedabove.
COS-7 cells were maintained in DMEM supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin and 100 mg/ml streptomycin(Invitrogen,Carlsbad,CA,USA).Cellswereincubatedat37°Cin humidifiedaircontaining5%CO 2 .Onedaypriortotransfection,1×10 4 COS-7 cells were grown on collagen-coated (0.48 mg/ml collagen; BD Bio sciences, Franklin Lakes, NJ, USA) coverslips (Knittel Gläser, Braun schweig,Germany)in24-wellplates.Transfectionwasdoneusing Fugene 6 transfection reagent according to manufacturer's protocol (Roche): 200 ng of wild-type or mutant MC4R expression vector was transfected at a 3:1 ratio to Fugene 6 transfection reagent. 24 h after transfection,plasmamembraneswerefluorescentlystainedwith1mg/ml tetramethyl-rhodamine wheat germ agglutinin conjugate (Invitrogen). Afterstaining,cellswerefixedwith4%formaldehydeandmountedon microscopeslides.VectashieldMountingmedium(VectorLaboratories, Burlingame, CA, USA) was used to preserve fluorescence. Cells were visualized using a Zeiss LSM 510 confocal microscope equipped with argon(excitation,488nm)andhelium-neon(excitation,543and633nm) lasers. Beckers/Zegers/deFreitas/Peeters/Verhulst/ Massa/VanGaal/Timmermans/Desager/ VanHul course of this study, P260Q and Q307X were also described [45, 46] .Characteristicsoftheprobandsaregivenintable2. For all mutation carriers, we tried to contact parents and otherfamilymemberstodeterminewhetherthemutationcosegregateswithobesity.WecouldonlyincludefamilymembersfortheprobandscarryingD90NandF280L.
The mother of the proband with D90N was also obese (BMI = 43.5 kg/m 2 ) and was found to carry the same mutation. No other family members were available, but familial anamnesisreportsoverweightinboththemother'sandthefather'sfamily.Thefather,whowasnotwillingtoparticipatein the study, was also reported to be morbidly obese (BMI = 43.6kg/m 2 ). WhenstudyingthefamilyoftheprobandwithF280L,we clearly demonstrated that this mutation co-segregates with obesity( fig.1 ).Wefurtherfoundthatthemutationwasinher-
Intracellular Signaling of Mutant Receptor
Wild-type MC4R cloned in the mammalian expression vector pcDNA3 was kindly provided by Dr. G. Yeo (Cambridge, UK). Mutant MC4Rs were created with a Quikchange Site Directed Mutagenesis kit (Stratagene,LaJolla,CA,USA)accordingtothemanufacturer'sprotocol.All clonedproductsweresequencedusingastandardsequencingprotocolas described above. HEK293T cells were maintained in DMEM supplementedwith10%FCS,100units/mlpenicillinand100mg/mlstreptomycin(Invitrogen).Cellswereincubatedat37°Cinhumidifiedaircontain-ing 5% CO 2 . Intracellular signaling capacity of mutant receptors was determined using a cAMP responsive luciferase construct (pCRE-Luc; Stratagene).Onedaybeforetransfection,1.5×10 4 cellswereseededona 96-well plate. Cells were transfected with 25 ng wild-type or mutant MC4R expression vector, 25 ng pCRE-Luc and 2.5 ng internal control plasmid pRL-TK, which constitutively expresses Renilla luciferase. Transfections were carried out using Fugene 6 transfection reagent accordingtothemanufacturer'sprotocol(Roche).24haftertransfection, cellswerestimulatedwithvaryingconcentrationsofα-MSH(10 -5 to10 -10 mol/l; Bachem, Well-am-Rein, Germany) diluted in culture medium. Cellswereallowedtoincubatefor3hinthepresenceofα-MSH.Then thecellswerelysedandFireflyandRenillaluciferasesweresequentially activated and quenched using the Dual-Glo Luciferase assay System (Promega,Madison,WI,USA).LuminescencewasdetectedwithaVictor 2 MultilabelPlateReader(PerkinElmer,Waltham,MA,USA).Forall experimentalconstructs,theassaywasrepeatedfourtimes.Theratioof firefly-to-renilla luciferase luminescence was calculated to correct data for transfection efficiency. Data for experimental constructs were all normalizedtothefirefly-to-renillaratioforwild-typeMC4Rstimulated with10 -5 mol/lα-MSH(setat100%).
Results
ScreeningofMC4Rinourpatientandcontrolpopulationre-vealed11sequencevariations.Threeofthesewerefoundin both our patient and control population (V103I, I198I and I251L). G324G was only identified in a control individual whileT112Mwasonlyfoundinanobeseindividual,butthis varianthaspreviouslybeenreportedasapolymorphism [22, 41] .V103IandI251Lwerealsopreviouslydescribedaspoly-morphisms;theirminorallelesleadtoaslightlyreducedbody weight [42, 43] . The mutations D90N, I186V, M200V, P260Q, F280L and Q307X were each found heterozygously in single, obese probands, but not in our control population. D90N and M200V have been described previously [17, 44] Functional characterization was performed for the two newlyidentifiedmutations(I186VandF280L)andforP260Q since the experiments performed here had not been previouslydescribedforthismutation.Theothermutationswere not included in the functional analysis since they had been previouslycharacterized [44, 45, 47, 48] .
ited from the mother. Furthermore, the maternal grandmother, uncle and great-uncle also harbored this mutation. Allmutationcarrierswereseverelyobese.Theleanyounger sisteroftheprobandwasfoundtocarrywild-typeMC4R.The obese father (BMI = 31.9 kg/m 2 ) was not included in the familyanalysis. MC4Rmutationfrequencyof5.3%.Thisisincontrasttoour previousstudyinwhichwedidnotidentifyanyMC4Rmuta-tions in a cohort of 123 overweight and obese children and adolescents [39] .
However,therearesignificantdifferencesbetweenthetwo study populations. In our first study, the study cohort had consisted almost entirely of adolescents (3 children vs. 120 adolescents)whilewenowstudiedapopulationof71children (age<12years)and41adolescents(age≥12years).Furthermore,themeanageoftheadolescentsamplewasalsohigher inourinitialstudy(meanage=16.8years)thaninthecurrent cohort (mean age = 14.1 years). The entire cohort now also includesmuchyoungerchildrenthanthosefromtheprevious report (age range = 0.4-19 years vs. 8-20 years). Therefore, weconcludethatourpopulationnowconsistsofchildrenwith early-onset obesity while our previous report probably containedalargenumberofpatientswithpubertalonsetofobesity. Furthermore, our first study only included children of Caucasiandescentwhilethesecondcohortalsocontainsindividualsofotherancestries.Finally,thefirstgroupofchildren and adolescents was recruited through an adult outpatient obesity clinic while the second group has been recruited through specific pediatric obesity centers in Antwerp and Hasselt. These differences may explain why we now find MC4Rmutationsatahighfrequencyinourpopulationwhile we did not detect any mutation previously. The current frequencyisinlinewithotherstudiesdealingwithchildrenwith severeearly-onsetobesity [18, 19, 30] .
In total, 11 sequence variations were found in our study. Four of these variations (V103I, T112M, I198I and I251L) are previously reported polymorphisms while another one (G324G)isunreported,butsinceitisasynonymousmutation which we found in a control subject, we are convinced that thispolymorphismisnotrelatedtoobesity.
Ontheotherhand,severalargumentsfavorthehypothesis that the remaining 6 variations are disease-causing. None of these is found in a control cohort, and they cause either an aminoacidsubstitutionoranearlystopcodon.Furthermore, 4variationshavebeenpreviouslyreportedinobesepatients, andthedisease-causingaspectofsomehasbeenconfirmedin functionalstudies.
TheD90Nmutationwasfirstreportedinasingleproband by Biebermann and colleagues in 2003 [44] . This mutation wasfoundinapatientwithearly-onsetobesity,butnoconclusions on segregation with obesity could be drawn since the mother did not carry the mutation and the father was not available for inclusion. Functional characterization demonstratedthatthismutationdidnotaltercellsurfaceexpression orligandbinding.However,nointracellularcAMPaccumulation was observed after stimulation with NDP-α-MSH. Cotransfection studies and a sandwich ELISA showed that the D90N mutation exerts its pathogenic effect through a dominant negative influence on the wild-type receptor. This was thefirstmutationinwhichadominantnegativeeffectcould The 3 mutant constructs were created in a mammalian pEGFP-N1expressionvectortostudycellularlocalizationof thesemutants.Imagesoftransfectedcellsweremadewitha confocal microscope. Wild-type MC4R is located on the plasmamembrane (fig.2B ).ConfocalimagingofP260Qand F280Lshowedthatbothmutationsareretainedintracellularly ( fig.2D-E) .ForI186V,wedemonstrateherethatthemutationdoesnotaltermembraneexpressionoftheprotein.ColocalizationofEGFPandtetramethyl-rhodaminewheat-germ agglutininconjugate(TMR-WGA)isclearlypresent( fig.2C ).
For the I186V mutation, we also performed a luciferase assaytodeterminetheabilityofthemutantreceptortostimulate cAMP production in response to α-MSH. We also includedtheP260Qmutationinthisassaytocompareourre-sultswiththoseobtainedbyStutzmannetal. [45] duringthe course of our study. For this experiment, both mutant constructswerecreatedinamammalianpcDNA3expressionvec-tor.Measurementofluciferaseasanindirectmeasureofintracellular cAMP showed complete loss of function for the I186Vmutation (fig.3) .Atmaximalstimulation,thismutant receptor only showed 1.7% of activation compared to the wild-typereceptor.P260Qcausedaseverereductioninintra-cellular signalingcapacity,asdemonstratedbyamaximalactivationof7.9%comparedtowildtype( fig.3 ).
Discussion
MC4R deficiency is widely accepted as the most common cause of monogenic obesity. In children presenting with severe early-onset obesity, screening of MC4R is therefore a first step in determining a possible genetic cause of the disease.WescreenedthecodingregionofMC4Rinapopulation of 112 severely overweight and obese children and adolescents and identified 6 mutation carriers, amounting to an X-Raid01:01_Arbeiten:Karger:Karger_Zeitschriften_2010:2010_obesity_facts:Ofa_5_10_94462:03_texte:OFA_5_10_201003011Beckers_ZS.doc 15 mann et al. [45] . Furthermore, a recent report describes a F261SmutationinaChineseprobandthatcausesintracellular retentionofthemutantreceptor [50] .Thesedataalsosuggest that this region in the 6th TM domain of MC4R may be an importantregionforthecellularlocalizationofthereceptor.
We were able to identify 2 previously unreported mutations, F280L and I186V. We found the F280L mutation in a severelyobesegirlof12years.Thismutationco-segregatedin the family from the mother's side. The proband's lean youngersisterwaswildtypeforMC4R.Theobesefatherwas not willing to participate, but we showed that the diseasecausingmutationisinheritedfromthemother.Wedeveloped anEGFP-MC4Rfusionprotein,whichallowedustoconclude thatthemutantreceptorislocalizedinsidethecellinsteadof ontheplasmamembrane.Therefore,wehypothesizethatthe intracellular retention of the mutant receptor causes a reducedinhibitionoffoodintakeinthisfamily,ultimatelyleadingtotheobservedobesity.
A7-year-oldobesegirlwasfoundtocarrytheI186Vmuta-tioninthe4thTMdomainofMC4R.Hermotherisofnormal weight(BMI=23.7kg/m 2 )whileherfatherisalsoobese(BMI= 31.8kg/m 2 ).Parents,however,werenotavailableforgenetic screening.Confocalimagingshowedthatthismutationisexpressed on the cell surface similar to wild type. By indirect cAMPmeasurements,wewereabletodemonstratethatthis mutation causes a complete loss of function of the receptor. However, we cannot conclude whether this is caused by a defectinligandbindingorintracellularsignalingaswedidnot performbindingassays.AG181DmutationinTM4hasbeen previouslyreportedandwasalsofoundtocauseacomplete loss of function as determined by measurement of intracellular second messenger production and ligand-binding assay [10, 51] .ThesedatastronglysuggestthattheI186Vmutation is pathogenic and is the cause of the obesity seen in the proband.
In conclusion, we identified 6 mutations in patients with early-onsetobesity,indicatingamutationfrequencyof5.3% inthispopulationofBelgianobesechildren.Two(I186Vand F280L) of the mutations were novel. Functional analysis on theseandonathirdmutation(P260Q)indicatedthat2ofthe 3 mutations cause intracellular retention of mutant MC4R. This has been shown to be the most common mechanism through which mutations impair MC4R signaling [29] [30] [31] . It has been shown that 81.3% of childhood obesity-associated mutationsinMC4Rcauseintracellularretentionoftherecep-tor.Thismaycorrelatewithanearlyonsetoftheobesityseen in the probands carrying these mutations [29] . Furthermore, Tao and Segaloff [52] proposed a classification scheme for MC4R mutations which identifies mutations that impair cell surfaceexpressionasanimportantclassofpathogenicmutations(classIImutations).FortheI186Vmutation,acomplete loss of intracellular signaling activity could be demonstrated here. This study again stresses the relevance of performing mutationanalysisofMC4Rinobesechildren.
bedemonstrated [44] .Inthecurrentstudy,wealsodetected thismutationinasingleprobandwithearly-onsetobesity.We werealsoabletoincludetheobesemotherinouranalysisand demonstratedthatshecarriedthismutationtoo.Basedonthe clinical data, co-segregation with obesity and the functional effects demonstrated by others, we conclude that the D90N mutation is the cause of the early-onset obesity seen in our patient.
Branson and colleagues [17] first described two patients withaM200Vmutationinthefifthtransmembrane(TM)domainofMC4R.Thesepatientswereobeseandhadcharacteristicsofbingeeating.Functionaldescriptionofthismutation showed that no difference from wild type could be demonstratedforcellsurfaceexpression,ligandbindingorintracellularsignalingcapacity [47] .Wealsoidentifiedanobesepatient carrying this mutation. His father is of normal weight (BMI=23.9kg/m 2 ),buthismotherhasahistoryofobesity. ShehasaBMIof38.5kg/m 2 aftergastricbanding.Sincenone oftheparentswereavailableforgeneticscreening,noconclusiononsegregationwithobesitycanbedrawn.Therefore,we cannotmakeanydefiniteconclusionsonthepathogeniccharacterofthismutationatthemoment.However,thefactthat thismutationhasnotbeenidentifiedincontrolsubjectsbyus orothers [17] leadsustospeculatethatitmayhaveanegative effectonMC4Rthatisnotidentifiablethroughthefunctional assayscurrentlyperformed.Furtherfunctionaltestingofthis mutationisthereforenecessarytofurtherelucidateitseffect onMC4Rfunctioning.
Thenonsensemutationatcodon307(Q307X)wasinitially identifiedinan8-year-oldobeseboy [46] .Nofunctionalcharacterizationofthismutantwasperformedatthattime.Here, weidentifiedthisnonsensemutationina14-year-oldgirlwith severeobesity.Nofamilydataareavailable.Wedidnotperformfunctionalassaysforthismutationsinceithasbeenpreviously described that truncation of the MC4R from codon 306onwardsresultsinalossofcellsurfaceexpressionofthe truncated receptor [48] . Furthermore, the di-isoleucine sequenceatcodons316/317wasshowntobecrucialforcellsur-faceexpressionofthereceptor [49] .Basedontheseprevious data,weconcludethattheQ307Xnonsensemutationfound inourpatientandthepreviouslyreportedcase [46] resultsin a truncated receptor which has lost the ability to be transportedtothecellsurface.
TheP260Qmutationwasidentifiedina10-year-oldpatient withsevereearly-onsetobesity.Nofamilydataareavailable forthisproband.Duringthecourseofourfunctionalexperiments, Stutzmann et al. [45] 
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